WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke EZRA wurde als Wortmarke am 19.03.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1495388 |
| Länder | 
|
| Basismarke |
Nr. ,
11. Oktober 2024
|
| Anmeldedatum | 19. März 2019 |
| Ablaufdatum | 19. März 2029 |
Markeninhaber
1182 Broadway, #14B
New York NY 10001
US
New York NY 10001
US
Markenvertreter
Lowenstein Sandler LLP,
One Lowenstein Drive
US
Waren und Dienstleistungen
09
Downloadable software featuring the use of artificial
intelligence (AI) for interpreting MRI scans for the
purposes of detecting cancer and other health risks;
downloadable software in the nature of a mobile application
for recording, analysis, storage, manipulation and
organization of MRI results, health screening results,
genetic and molecular data; downloadable software in the
nature of a mobile application for providing access to
multiple databases that contain aggregated results of
molecular biology testing and genotyping; downloadable
publications in the nature of electronic reports, articles,
bulletins, newsletters in the fields of cancer screening,
health screening, genetic testing, genotyping technologies,
genetic screening, phenotyping, molecular analytics, and
ancestry
41
Providing an online resource center, namely, online
non-downloadable articles and papers in the fields of cancer
screening tests, genetic testing and genotype technologies;
providing a website featuring online non-downloadable
publications in the nature of articles, journals, brochures,
leaflets, guides and manuals in the fields of cancer
screening tests, genetic testing and genotype technologies
(terms considered too vague by the International Bureau -
rule 13 (2) (b) of the Common Regulations); providing online
non-downloadable educational publications in the fields of
cancer screening tests, genetic testing and genotype
technologies
42
Providing scientific analysis and informational reports
based upon results of laboratory testing for cancer
detection and health screening purposes; providing
scientific analysis and informational reports based upon
results of laboratory testing in the field of genetics;
providing temporary use of online non-downloadable software
featuring the use of artificial intelligence (AI) for
interpreting mri scans for the purposes of detecting cancer
and other health risks; providing temporary use of online
non-downloadable software for recording, analysis, storage,
manipulation and organization of MRI results, health
screening results, genetic and molecular data; providing
online computer databases featuring information based on
aggregated results of genotyping; application service
provider (ASP) featuring software for providing access to
multiple databases that contain aggregated results of
genotyping; application service provider (ASP) featuring
software for use in data management, data storage, data
analysis, report generation, user identification, and
membership identification, all in the fields of genetics,
genetic testing, genetic screening, genotyping, phenotyping,
molecular analytics, and ancestry; scientific research in
the fields of genetics, genetic testing, genetic screening,
genotyping, phenotyping, molecular analytics, and ancestry
44
Health care services for treating prostate cancer and other
cancers; health care services, namely, disease management
programs; health screening services in the field of prostate
cancer, and other cancers; counseling services in the fields
of health, nutrition and lifestyle wellness; providing
health care information by individual and group counseling;
wellness and health-related consulting services; health care
services, namely, wellness programs; medical imaging
services; human healthcare services namely, treatment of
prostate cancer and other cancers; medical services for the
diagnosis of conditions of the human body, namely, prostate
cancer, breast cancer, speech disorders, and infertility
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 14. Juli 2023 | 2023/29 Gaz | CA | Ablehnung |
| 25. Oktober 2022 | 2022/43 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. Mai 2022 | 2022/21 Gaz | AU | Ablehnung |
| 01. März 2022 | 2022/11 Gaz | Korrektur | |
| 24. Juni 2021 | 2021/26 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 10. Dezember 2020 | 2020/50 Gaz | JP | Ablehnung |
| 08. April 2020 | 2020/15 Gaz | EM | Ablehnung |
| 19. März 2019 | 2019/42 Gaz | US | Eintragung |
ID: 141495388